Member Info for ChasPB

Agreed.

A lot of Africa, South America, Central Asia haven't Tested/Vaccinated their people yet, so there's a large slice of the global market to trade with.

Would you want to sit on a plane not knowing if the people around you are Negative or not?

Many countries want you to have a PCR test before departure, its not only about what our Government wants anymore.

mgmidget - Thx for your reply

Boosters that follow on from Vaccinations when your young (supposedly) cover you for 5-10 years+ depending on Infection type for protection.

I'm guessing nobody knows at present re Covid, but could the Vaccination rounds start again next Spring for everybody that wants them? or will it just be Booster after Booster topping up as we go along.

Surely Testing will play a part in this as they wont want to waste the cost of unnecessary vaccinations if not needed?

What amount of time does somebody having both Vaccinations and possibly a forth coming Booster protect for?

e.g. - Vac 1 Dec 20, Vac 2 Mar 21, Booster Oct/Nov 21 - I'm thinking 16 - 18 months

Wonder if our Accountants can work out if we can offset or claw back some Tax on this Write off / down?

HillS - thx for the viewpoint

Do you think if NCYT were to place a Share Buy-Back order with a limit say £3.60, the MM to cover the order would need to purchase the shares in Market at less than £3.60 so as to turn a profit (thereby holding down the SP until the order is filled)?

I

Covid Variant: MU is now the infecting more people in USA than Delta Variant.
It is (unfortunately) leading Variant in 47 of the 50 states.

The World Health Organisation announced last week it was monitoring a new Covid-19 variant which had become a concern after it was found to be potentially resistant to natural immunity.

Understand very few Cases in UK so is only regarded as VOI (Variant of Interest), however with the speed this is infecting people may this will become VOC (Concern) this Autumn

https://www.leicestermercury.co.uk/news/leicester-news/mu-covid-19-variant-what-5900308

Perhaps RNS tomorrow with Agenda/Proposals as we will be only 21 days away from meeting?

Could give the SP a little nudge as we open?

2/3 or Investor Base in France - Mentioned in last months Investor Presentation - Q & A (56m 50s) now on Novacyts Website

https://novacyt.com/investor-event-2021/

My line of thought:

Was last years BUY Back resolution only for 1 year only?

if so Raise it again for coming year.

Can, if necessary utilise it in New Year when Year End results show £170m -£200m in Bank.

Plus of course if we are successful with DHSC, maybe even more.

So Monday morning (before Markets open?) we may get an RNS with details of the forthcoming AGM and proposals to Vote on.

Is there anything that could be proposed (e.g. New Share Buy Back) which may impact the SP when markets open?

Expresstest now advertising on TV for "GOLD Standard" testing - are we involved?

All our tests have been listed by the UK Government and our PCR tests are analysed in established laboratories to deliver gold standard COVID-19 results.

https://www.expresstest.co.uk/?gclid=EAIaIQobChMI2t7cmvHa8gIVpejtCh07DA05EAAYASAAEgKwxfD_BwE

French Market closed (16:30 UK time) UP 0.45%

Steve Brine is a British Conservative Party politician who has served as the Member of Parliament for Winchester AND Chandlers Ford since 2010.
**************************************************************************************************************************

I have previously written to Steve Brine MP, asking him to promote or push forward Novacyt as they are in his Chandlers Ford Constituency, but never had as much as an acknowledgement from him

On BBC now:

https://www.bbc.co.uk/news/uk-england-coventry-warwickshire-58357327

New Covid test rules out: New LFTs preferred criteria to be biodegradable, this may be an industry wide requirement?

Perhaps somebody from SYM should chat to NOVACYT (NCYT), another small AIM company, but are growing due to their "Gold standard" COVID test kits, making £100m profit per year.

Could be a great partnership for SYM/NCYT ???

Thought the late reported (18:11) trade of 45k (£180k) May have underpinned the opening SP this morning.

What is the worth of this Corporation Taxable Benefit? Any ideas?

Quote from the Presentationj:
It is worth noting that we have a considerable upside in Corporation Tax if we can avail of Patent Box relief which would be applicable as when patents are granted.
This is a UK scheme that allows a reduced rate of Corporation Tax on those profits covered by Novel Patents.
The credit can be backdated on the profits earned from the time the patent was applied for,

Thx Kaeren / Wilson

Does that mean if WQ placed a BUY "Limit" order (e.g. 4.28, so as to reduce their Short position but wanted to control the price to be paid, this could keep the SP in a trading range (4.22 - 4.32) until order fulfilled? and then the MM would let it float naturally?

Don't forget this bit of business earlier this year:

UNICEF has purchased and shipped 1.2 million COVID-19 PCR tests to Ukraine to support the Government’s efforts to address the pandemic in the country. The assistance became available due to the financial support from the World Bank in cooperation with the Ministry of Health of Ukraine.

The COVID-19 genesig Real-Time PCR tests are produced by Primerdesign Ltd in the United Kingdom. In accordance with the Ministry’s plan, the tests will be transferred to Ukrvaktsyna for further distribution across Ukraine.

The assistance, worth US$13.5 million in supplies and services, will provide state health care institutions with access to 1.2 million COVID-19 PRC tests free of charge. The World Bank’s overall support to COVID-19 testing, including rapid antigen tests, amounts to US$ 15.5 million so far.

https://reliefweb.int/report/ukraine/world-bank-and-unicef-deliver-12-million-covid-19-pcr-tests-ukraine-enuk

World Bank could be a very important Customer to us as Autumn/Winter draws near.

Shares in diagnostics business Novacyt jump as it records sales rise

https://www.standard.co.uk/business/nyct-shares-diagnostics-novacyt-records-higher-sales-b951218.html